Find Research Projects

Search results

• HER2CLIMB: CTU: A randomized, double-blind, phase 3 study of tucatinib or placebo in combination with trastuzumab and pertuzumab as maintenance therapy for metastatic HER2+ breast cancer (HER2CLIMB-05)

  Sabanathan, D., Chester, C. & Chapman, N.

  4/08/22 → 23/02/27

  Project: Research

• FT22: Arab/Muslim Australian Social Movements since the 1970s: a hidden history

  Abdel Fattah, R.

  28/02/23 → 26/02/27

  Project: Research

• 9785-CL-0123: CTU: A Phase 2 Open-label Extension Study for Subjects with Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

  Gurney, H., Chester, C. & Chapman, N.

  6/07/22 → 20/03/27

  Project: Research

• NIMBLE: CTU 52-week, randomised, double-blind, double-dummy, parallel group, multi-centre, non-inferiority study assessing exacerbation rate, additional measures of asthma control and safety in adult and adolescent severe asthmatic participants with an eosinophilic phenotype treated with GSK3511294 compared with mepolizumab or benralizumab

  Farah, C., Chester, C. & Chapman, N.

  1/06/22 → 27/03/27

  Project: Research

• BAT-7104-002-CR: CTU: A Phase 1, Multi-Center, Open-Label Study to Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT7104 in Patients with Advanced Solid Tumours

  Park, J., Chester, C. & Chapman, N.

  23/06/22 → 30/03/27

  Project: Research

• C4201002: CTU: A PHASE 1, OPEN-LABEL, MULTI-CENTER, DOSE-FINDING, PHARMACOKINETIC, SAFETY AND TOLERABILITY STUDY OF PF-07265807 IN PARTICIPANTS WITH SELECTED ADVANCED OR METASTATIC SOLID TUMOR MALIGNANCIES

  Park, J., Chester, C. & Chapman, N.

  18/09/22 → 31/03/27

  Project: Research

• DB-1303-O-1001: CTU A Multicenter, Open Label, Non-Randomized First-in-Human Phase I/II Study to Assess the Safety, Tolerability, PK, PD and Preliminary Anti-Tumor Activity of DB1303 in Subjects with Advanced Solid Malignant Tumors

  Sabanathan, D., Chester, C. & Chapman, N.

  16/05/22 → 4/04/27

  Project: Research

• YH002004: CTU A multicenter, open-label, phase I dose escalation study to evaluate the safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of YH002 in combination with YH001 in subjects with advanced solid tumors

  Gurney, H., Chester, C. & Chapman, N.

  2/05/22 → 18/04/27

  Project: Research

• VT3996-301: CTU: An Open-Label, Multicenter Phase 1b/2 Study of Nanatinostat and Valganciclovir in Patients with Advanced Epstein-Barr Virus-Positive (EBV+) Solid Tumors and in Combination with Pembrolizumab in Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma

  Park, J., Chapman, N. & Chester, C.

  21/06/22 → 27/04/27

  Project: Research

• Keynote-C14: CTU: A Phase II, Open-Label, Multicenter Study of Olinvacimab in Combination with Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer

  Sabanathan, D., Chester, C. & Chapman, N.

  4/08/22 → 27/04/27

  Project: Research

• LM302-01-201: CTU A Phase I/II, Open-Label, Multiple Centre Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of LM302 in Combination with Toripalimab in Patients with Advanced Solid Tumors

  Smith, J., Chester, C. & Chapman, N.

  20/06/22 → 27/04/27

  Project: Research

• A PRIORI: Aortix Therapy for Perioperative Reduction of Renal Injury (A PRIORI)

  Worthley, S., Chapman, N. & Chester, C.

  9/05/22 → 28/04/27

  Project: Research

• CO42865: CTU: A Phase III, Randomized, Open-Label Study of Pralsetinib Versus Standard of Care for Treatment of Ret-Mutated Medullary Thyroid Cancer

  Sabanathan, D., Chapman, N. & Chester, C.

  30/04/22 → 30/04/27

  Project: Research

• STOPIt: Study of Tofacitinib for the treatment of chronic pouchitis (StopIt)

  Leong, R., Chapman, N. & Chester, C.

  12/05/22 → 11/05/27

  Project: Research

• 1397-0012: CTU: A randomised, double-blind, placebo-controlled, parallel group, dose-finding study evaluating efficacy, safety and tolerability of BI 1291583 qd over at least 24 weeks in patients with bronchiectasis

  Morgan, L., Chapman, N. & Chester, C.

  22/06/22 → 25/05/27

  Project: Research

• ADG126-1001: CTU: A First-in-Human (FIH), Open-Label, Phase I Dose Escalation and Expansion Study of ADG126, ADG126 in Combination with Toripalimab, and ADG126 in Combination with ADG106 in Patients with Advanced/Metastatic Solid Tumors

  Park, J., Chapman, N. & Chester, C.

  25/05/22 → 26/05/27

  Project: Research

• REAL: A Phase 2a Open-Label Preliminary Safety, Efficacy, and Biomarker Study of WP-0512 in Patients with Amyotrophic Lateral Sclerosis (ALS) REAL (Rho kinasE in ALs)

  Rowe, D., Gan, R. & Ordonez Artunduaga, P.

  13/05/22 → 31/05/27

  Project: Research

• Decrescendo: CTU: De-escalation of adjuvant chemotherapy in HER2-positive, estrogen receptor-negative, node-negative early breast cancer subjects who achieved pathological complete response after neoadjuvant chemotherapy and dual HER2-blockade

  Sabanathan, D., Chester, C. & Chapman, N.

  1/09/22 → 9/06/27

  Project: Research

• IMMU-132-11: CTU A PHASE 2 OPEN-LABEL STUDY OF SACITUZUMAB GOVITECAN (IMMU-132) IN SUBJECTS WITH METASTATIC SOLID TUMORS

  Zhang, A., Chapman, N. & Chester, C.

  7/07/22 → 15/06/27

  Project: Research

• ANFF Optofab OPEX cofunding 2023-2027

  Withford, M.

  1/07/23 → 30/06/27

  Project: Research

• MEND: A Phase 1 Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy Study of Oral Monepantel in patients with ALS/Motor Neuron Disease

  Rowe, D., Gan, R., Ordonez Artunduaga, P. & Kalband, B.

  1/07/22 → 30/06/27

  Project: Research

• Making INROADS: RCT of a web-based early intervention to interrupt the vicious cycle of co-occurring anxiety and alcohol use among young adults

  Stapinski, L., Baillie, A., Prior, K., Teesson, M., Lee, Y. Y., Deady, M., Rapee, R., Hudson, J. & Kay-Lambkin, F.

  1/07/22 → 30/06/27

  Project: Research

• D3S-001-100: CTU: A Phase 1, Open Label, Dose Escalation and Dose Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of D3S 001 Monotherapy in Subjects with Advanced Solid Tumors with a KRAS p.G12C Mutation

  Park, J., Chester, C. & Chapman, N.

  24/08/22 → 13/07/27

  Project: Research

• HLX14-002-PMOP301: CTU: Randomized, Double-Blind, International Multicenter, Parallel-Controlled Phase III Clinical Study to Evaluate Recombinant Anti-RANKL Human Monoclonal Antibody Injection (HLX14) Versus Denosumab Injection (Prolia®) in Postmenopausal Women with Osteoporosis at High Risk of Fracture

  Preda, V., Chester, C. & Chapman, N.

  18/07/22 → 17/07/27

  Project: Research

• Litespark: CTU A Multicenter, Open-label, Randomized, Phase 1/2 Study of Belzutifan in Combination with Palbociclib Versus Belzutifan Monotherapy in Participants with Advanced Renal Cell Carcinoma

  Gurney, H., Chapman, N. & Chester, C.

  3/08/22 → 18/07/27

  Project: Research

• UNSW Led: Enhancing hepatitis C testing and treatment among people who inject drugs in drug treatment settings: the ETHOS III Study

  Grebely, J., Dore, G. J., Marshall, A. D., Treloar, C., Gray, R. T., Shih, S., Degenhardt, L., Amin, J., Read, P., Salehi Alavi, M., Montebello, M. E., Christmass, M., Gorton, C., Milat, A., Lam , T., Wiseman, V. & Law, M.

  28/07/22 → 27/07/27

  Project: Research

• REDUCE: CTU: Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema

  Ing, A., Chester, C. & Chapman, N.

  4/11/22 → 27/07/27

  Project: Research

• CONVERT: CTU: Fissure closure with the AeriSeal System for CONVERTing collateral ventilation status is patients with severe emphysema: a multicentre, prospective trial

  Ing, A., Chapman, N. & Chester, C.

  4/11/22 → 29/07/27

  Project: Research

• JNJ-80954385LYM1001: CTU Phase i first in human study of a first in class CD79bxCD20xCD3 trispecific antibody JNJ-80948543 in B-cell lymphoid malignancies

  Di Ciaccio, P., Chapman, N. & Chester, C.

  6/09/22 → 8/08/27

  Project: Research

• Development of digital twin model based on physico-chemical and biosensors to estimate end-of-service life of sewers

  Withford, M., Ams, M. & Dekker, P.

  1/09/23 → 31/08/27

  Project: Research

  File

• SmartCrete CRC

  Clark, S., Wu, S., Salehi, F., Bishop, M., Trueck, S., Linnenluecke, M., Mukhopadhyay, S., Sheng, M., Beheshti, A., Hansen, S., Dekker, P., Jackson, S., Asadniaye Fard Jahromi, M., Wiggins, M., Ams, M., Withford, M., Beheshti, A., Dafforn, K., Giri, P., Sofronov, G., Taheri, S. & Abbassi, R.

  Macquarie University

  21/09/20 → 20/09/27

  Project: Research

• SURF-301: CTU: A Multicenter, Open-label Phase 1/2 Study of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors with Activating FGFR3 Gene Alterations (SURF-301)

  Zhang, A., Chester, C. & Chapman, N.

  31/10/22 → 28/09/27

  Project: Research

• COESB: ARC Centre of Excellence in Synthetic Biology

  Paulsen, I., Filipovska, A., Parker, R., Nielsen, L. K., Neilan, B. A., Alexandrov, K., Jackson , C., Wodak, J., Rackham, O., Marcellin, E., Gillings, M., Rogers, W., Lee, L., Packer, N., O'Hara, I. M., Speight, R., Vickers, C. E., Beliaev, A., Scott, C., Lacey, J., Mankad, A., Calvert, J., Thomas, G., Rodriguez-Concepcion, M., Fleishman, S., Koepke, M., Ball, M., Turner, N. J., Borneman, A. R., Holowko, M., Goold, H., Ellis, T., Mitchell, L. A. & Dai, J.

  9/11/20 → 8/11/27

  Project: Research

• NOE-CFD-201: CTU: A Double-blind, Placebo-controlled, Phase IIb, Multi-center, Ten-week Prospective Study to Evaluate the Efficacy and Safety of NOE-105 in Adult Male Patients with Childhood Onset Fluency Disorder

  Kalband, B., Chester, C. & Chapman, N.

  22/11/22 → 21/11/27

  Project: Research

• ARC Centre of Excellence for Plant Success in Nature and Agriculture

  Beveridge, C., Cooper, M., Brodribb, T., Waterhouse, P. M., Wright, I., Bowman, J., Burrage, K., Donovan, D., Foo, E., Jordan, D., Hammer, G., Henry, R., Holland, B., Ortiz-Barrientos, D., Sherman, B., Smith, S., Weller, J., Bett, K., Holbrook, N., Li, J., Lunn, J., Messina, C., Morris, G., Rieseberg, L., Taylor, J. & Trevaskis, B.

  4/12/20 → 3/12/27

  Project: Research

• INVESTIGATOR EL1: Platform Technologies for Antibiotic Resistance Diagnostics at Single-Cell Resolution

  Li, M.

  1/01/23 → 31/12/27

  Project: Research

• ICCRP: The International and Canadian Child Rights Partnership

  Doel-Mackaway, H.

  30/05/21 → 31/12/27

  Project: Research

• Policy For Self-Determination: the Case Study of ATSIC

  Holland, A.

  2/01/23 → 3/01/28

  Project: Research

• R&D and Innovation Hub with Fujitsu Australia

  Reed, M.

  28/02/23 → 22/01/28

  Project: Research

• Living Ports

  Dafforn, K., Bishop, M., Mayer-Pinto, M. & Goad, A.

  25/10/22 → 1/02/28

  Project: Research

• FL22: Literacy in adolescence: The next major challenge in the science of reading

  Castles, A.

  31/03/23 → 30/03/28

  Project: Research

• MISC - AAO: A Macquarie University home for the Australian Astronomical Observatory Instrumentation Group and A Collaborative Approach to Establishing a National Optical Astronomy Instrumentation Capability

  Steel, M.

  1/07/18 → 30/06/28

  Project: Research

• XL-Chem: Synthesizing our future

  Karuso, P. & Franck, X.

  5/10/20 → 29/12/28

  Project: Other

• DataX

  Selvadurai, N., Shang, H., Sowman, P. & Yang, J.

  1/01/23 → 31/12/28

  Project: Research

• TEE Study: Attracting, retaining and sustaining quality teachers in early education

  Wong, S., Fenech, M., Gibson, M., Garvis, S., Durksen, T. & Boyd, W.

  1/01/23 → 31/12/28

  Project: Research

• Blue Economy Cooperative Research Centre -Participants Agreement

  Abbassi, R., Bagnall, D., Salehi, F. & Li, M.

  1/01/20 → 30/06/29

  Project: Research

• Fred Stephens Fellowship in Colorectal Surgery

  Lam, V.

  26/05/21 → 31/12/30

  Project: Research

• Digital Finance, CRC, RegTech with Algorithmic Real-Time Enforcement, Australian government and industry partners, 2021-2031

  Selvadurai, N.

  1/07/21 → 30/06/31

  Project: Research

• $181million - DFCRC: Digital Finance Cooperative Research Centre

  Foley, S.

  12/09/21 → 1/11/31

  Project: Research

• Sir Asher Joel Foundation

  Davis, G.

  1/01/12 → 31/12/99

  Project: Other